A Free Service Provided By



Legal Topics

Arbitration and Mediation
Car Accidents
Child Support
Child Custody & Visitation

Copyright Law
Criminal Law
Dangerous Drugs
DUI Drunk Driving

Elderly Laws
Employees' Rights
Estate Planning
Family Law
Immigration Law

Lemon Law
Medical Malpractice
Megan's Law
Mesothelioma & Asbestos

Probate & Estates
Product Recalls
Real Estate

Statute of Limitations

Taxes & the IRS
Traffic Violations
Workers' Compensation
Work Related Injury

Privacy Policy

Contact Us

About Us

Facts - Books - News    U.S. Facts Of Law:

What Is Bextra

Bexta is an anti-inflammatory drug in a class of drugs known as non-steroidal anti-inflammatory drugs (NSAID's).  Bextra reduces inflammation, fever and pain by reducing substances in the body that cause these symptoms.

Bextra was used to treat painful menstruation, osteoarthritis, inflammation and adult rheumatoid arthritis.  Also known as Valdecoxib, the Bextra brand name was manufactured and distributed by Pfizer.

Bextra was removed from the market in 2005 at the request of the FDA due to concerns that it was related to cardiovascular problems including stroke and heart attack.


Bextra Best Sellers from

(no title)


Newsfeed display by CaRP

Bextra News
GN News

This RSS Feed URL Is Deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at

Pfizer Reaches Initial Deal Settling Celebrex, Bextra Suits Bloomberg
Pfizer Reaches Initial Deal Settling Celebrex, Bextra Suits Bloomberg Pfizer Inc. is settling a securities class action lawsuit accusing it of keeping investors in the dark about the cardiovascular risks of the arthritis drugs Celebrex and Bextra, avoiding what could have been a drawn out trial in the 12 year old case

Pfizer To Pay 486M To Settle Lawsuit Over Celebrex, Bextra The Consumerist
The Consumerist Pfizer To Pay 486M To Settle Lawsuit Over Celebrex, Bextra The Consumerist Issues with Bextra and Celebrex came to light in late 2004 when rival pharma biggie Merck withdrew a similar product associated with cardiovascular risks. Pfizer pulled Bextra from the U.S. market late the next year, and agreed in September 2009 to pay Pfizer to Pay 486 Million to Settle Securities all 6 news articles raquo

Pfizeraposs Bextra Settlement Tagged At 486M FiercePharma
FiercePharma Pfizer39s Bextra settlement tagged at 486M FiercePharma Pfizer said it has already accrued the money to resolve a Multi District Litigation relating to Celebrex and Bextra pending against the Company in New York federal court. Pfizer spokeswoman Neha Wadhwa today confirmed that was the settlement sum. In and more raquo

Pfizer Must Face Revived Celebrex, Bextra Safety Lawsuit Reuters
Reuters Pfizer must face revived Celebrex, Bextra safety lawsuit Reuters Shareholders accused the New York based company of having concealed tests that began in 1998 and suggested health risks associated with Celebrex and Bextra. Writing for the appeals court, Circuit Judge Debra Ann Livingston said Swain went astray in and more raquo

IMPORTANT NOTICE: This webpage is Copyrighted content.  No portion of this page may be copied to any other webpage, forum, blog or other domain page or offline publication without written permission from Violators will be prosecuted to the fullest extent of the law.

The information provided by does not constitute legal advice or any other type of advice and is provided for educational purposes only without warranty of any kind. has not reviewed the information on this page for accuracy and is not responsible for any errors, omissions or inaccuracies.  For legal advice you should consult a licensed attorney.


Copyright All Rights Reserved -
No Portion of This Page May Be Copied Without Written Permission

Facts of Law explaining what is bextra

Facts of Law - What Is Bextra